Free Trial

Nutex Health (NASDAQ:NUTX) Sees Strong Trading Volume - Here's Why

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) saw strong trading volume on Wednesday . 360,584 shares were traded during mid-day trading, an increase of 246% from the previous session's volume of 104,320 shares.The stock last traded at $90.35 and had previously closed at $100.01.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Maxim Group increased their price target on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Wall Street Zen lowered Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Finally, Benchmark raised their target price on Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th.

View Our Latest Analysis on Nutex Health

Nutex Health Trading Down 1.6%

The firm has a fifty day moving average of $130.49 and a two-hundred day moving average of $94.12. The company has a market cap of $523.81 million, a PE ratio of 7.92 and a beta of -0.04. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. The business had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Topline Capital Management LLC bought a new stake in shares of Nutex Health during the 4th quarter valued at about $5,690,000. American Century Companies Inc. bought a new stake in shares of Nutex Health during the 4th quarter valued at about $1,362,000. Ancora Advisors LLC bought a new stake in shares of Nutex Health during the 4th quarter valued at about $1,334,000. Russell Investments Group Ltd. bought a new stake in Nutex Health in the 4th quarter worth approximately $672,000. Finally, Informed Momentum Co LLC bought a new stake in Nutex Health in the 1st quarter worth approximately $868,000. Hedge funds and other institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Articles

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines